Literature DB >> 21915210

Novel synthesis of pseudopeptides bearing a difluoromethyl group by Ugi reaction and desulfanylation.

Jingjing Wu1, Hui Li, Song Cao.   

Abstract

Thirteen difluoromethyl-containing pseudopeptides were synthesized by Ugi reaction using the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2) as one component, followed by removal of the phenylsulfanyl protecting group in the presence of tributyltin hydride and azobisisobutyronitrile.

Entities:  

Keywords:  Ugi reaction; difluoromethyl functionality; gem-difluoromethylene-containing acid; pseudopeptides; reductive cleavage

Year:  2011        PMID: 21915210      PMCID: PMC3170163          DOI: 10.3762/bjoc.7.123

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

Fluorinated amino acids and pseudopeptides have increasingly attracted attention in recent years [1-5]. The selective incorporation of fluorine-containing groups, such as trifluoromethyl, difluoromethyl and difluoromethylene, into peptides or peptidomimetics often drastically alters the chemical, physical, and biological properties of the parent compounds [6-9]. Nowadays, difluoromethyl-containing compounds are increasingly being applied in pharmaceuticals and agrochemicals [10-12]. It is reported that difluoromethyl functionality (CF2H) is isosteric and isopolar to the hydroxyl group and can behave as a hydrogen donor through hydrogen bonding [13]. However, to date, most fluorine-containing peptide modifications involve the introduction of trifluoromethyl or difluoromethylene into molecules [14-18]. Only a few examples have been reported of the preparation and bioassay of pseudopeptides and peptidomimetics bearing difluoromethyl groups. For example, compound I can act as bradykinin B1 antagonist or inverse agonist and can be used in the prevention of inflammation and pain [19]. Compound II is an inhibitor of microsomal triglyceride transfer protein (MTP) and useful for the treatment of obesity and atherosclerosis (Figure 1) [20].
Figure 1

Two examples of bioactive pseudopeptides bearing a CF2H group.

Two examples of bioactive pseudopeptides bearing a CF2H group. Among the protocols for the preparation of pseudopeptide derivatives, the Ugi four-component reaction offers significant advantages over conventional linear-step synthesis [21]. Various fluorinated building blocks have been used in the Ugi four-component reaction to construct a fluorinated compound library [22-25]. Our group has always been interested in developing efficient methods for the preparation of difluoromethyl-containing compounds through multicomponent reactions [26-30]. Recently, we reported a novel and general strategy for the construction of a difluoromethyl compound library, and we further illustrated this strategy by application to the synthesis of CF2H-bearing pseudopeptides and 1,2,3-triazoles through Ugi and click reaction, respectively [27,30]. In continuation of our interest in the synthesis of diverse difluoromethyl-containing pseudopeptides, we herein report a novel and efficient synthesis of difluoromethyl-containing pseudopeptides through Ugi reaction, with gem-difluoromethylene-containing acid as a key component, followed by reductive cleavage of the phenylsulfanyl group (Scheme 1).
Scheme 1

Synthesis of difluoromethyl-containing pseudopeptides (4a–m) by Ugi reaction and desulfanylation.

Synthesis of difluoromethyl-containing pseudopeptides (4a–m) by Ugi reaction and desulfanylation.

Results and Discussion

For the purpose of screening novel bioactive compounds, we recently prepared a variety of diverse difluoromethyl-containing pseudopeptides. In our initial experiments, we tried to use difluoroacetic acid as one component to undergo Ugi reaction to prepare difluoromethyl-containing pseudopeptides. Unfortunately, the anticipated difluoromethyl-containing product 4a was not obtained (Scheme 2). Although there are a few examples of acetic acid and trifluoroacetic acid acting as substrates in an Ugi reaction [24,31], up to now, no literature was found concerning the use of difluoroacetic acid as one of the components in the Ugi reaction. For a comparative study, acetic acid and trifluoroacetic acid served as the substrates for the Ugi reaction under the same reaction conditions as those used for the difluoroacetic acid, and the results indicated that the reaction proceeded efficiently regardless of reaction conditions, and the Ugi products (5 and 6) were obtained in good yields. The hydrogen atom next to the CF2 group seems to influence the formation of Ugi product.
Scheme 2

The Ugi reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with acetic acid, difluoroacetic acid and trifluoroacetic acid in methanol or under solvent-free conditions.

The Ugi reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with acetic acid, difluoroacetic acid and trifluoroacetic acid in methanol or under solvent-free conditions. In previous studies, we developed a synthetic methodology to prepare functionalized small molecules having a CF2H group [27]. In this work, we first synthesized a protected difluoro-containing building block, 2,2-difluoro-2-(phenylthio)acetic acid (2). The synthesis of compound 2 is illustrated in Scheme 3. The ethyl 2,2-difluoro-2-(phenylthio)acetate (1) was readily prepared by the reaction of ethyl bromodifluoroacetate and thiophenol according to the known procedure [32]. The novel difluorinated acid 2 was obtained by hydrolysis of the ester under basic condition in nearly quantitative yield.
Scheme 3

Synthesis of 2,2-difluoro-2-(phenylthio)acetic acid (2).

Synthesis of 2,2-difluoro-2-(phenylthio)acetic acid (2). After successful synthesis of the protected functionalized CF2 building block 2, we tried to use it as one of the components in the preparations of the difluoromethylene-containing pseudopeptides by Ugi reaction. Indeed, the reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with 2 proceeded efficiently under solvent-free conditions. Finally, we removed the protecting group (PhS) with Bu3SnH/AIBN according to our previous research, and the desired difluoromethyl-containing pseudopeptide was successfully obtained [27]. To demonstrate the scope of the method, several different substituted anilines, substituted benzaldehydes, isocyanides and this novel difluorinated building block 2 were subjected to Ugi reaction under solvent-free conditions, followed by reductive cleavage of the phenylsulfanyl group. It was found that both Ugi reaction and desulfanylation proceeded smoothly for all substrates used to give the corresponding difluoromethylene-containing and difluoromethyl-containing pseudopeptides (3a–m and 4a–m) in good yields (Table 1).
Table 1

Synthesis of difluoromethylene-containing pseudopeptides (3a–m) and difluoromethyl-containing pseudopeptides (4a–m).


EntryR1R2R334
Yield (%)aYield (%)a

aPhPhBn8275
b2-MePhPhBn7868
c2-MePh4-MePhBn7574
d4-MeOPhPhBn7975
ePh4-MeOPhBn7870
f2-MePh4-MeOPhBn7467
g4-MePh4-MeOPhBn7278
h4-FPh4-MeOPhBn7071
iPh4-FPhBn7775
j2-MePh4-FPhBn7069
k4-MeOPh4-FPhBn7274
lPhPhPh6866
mPh4-MeOPhPh6660

aIsolated yield.

Synthesis of difluoromethylene-containing pseudopeptides (3a–m) and difluoromethyl-containing pseudopeptides (4a–m). aIsolated yield.

Conclusion

In summary, we have developed a novel and efficient protocol for the synthesis of CF2H-containing pseudopeptides by Ugi reaction of substituted anilines, benzaldehyde, isocyanides and the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2), followed by the cleavage of the phenylsulfanyl group.

Experimental

General

All reagents were of analytic grade, obtained from commercial suppliers and were used without further purification. Melting points were measured in an open capillary using Büchi melting point B-540 apparatus and are uncorrected. 1H NMR and 13C NMR spectra were recorded on a Bruker AM-400 spectrometer (400 MHz and 100 MHz, respectively) using TMS as internal standard. The 19F NMR were obtained using a Bruker AM-400 spectrometer (376 MHz) and the 19F NMR were measured with external CF3CO2H as standard. Gas chromatography-mass spectra (GC-MS) were recorded on HP 5973 MSD with 6890 GC. High resolution mass spectra (HRMS) were recorded under electron impact conditions using a MicroMass GCT CA 055 instrument and recorded on a MicroMass LCTTM spectrometer. Column chromatography was carried out with Merck 60 (230–400 mesh) silica gel.

General procedure for compounds 3a–m

To a stirred amine (1 mmol), the aldehyde (1 mmol) was added in portions for about 5 min. The mixture was stirred for 30 min at rt. Then, the reaction mixture was heated to 60 °C, and isocyanide (1 mmol) and 2,2-difluoro-2-(phenylthio)acetic acid (2) (1 mmol) were added. Stirring was continued at 60 °C for 1 h (TLC). The crude residue was purified by chromatography to give the desired products 3.

General procedure for compounds 4a–m

Bu3SnH (0.58 g, 2 mmol) was added under argon atmosphere to a solution of 3 (1 mmol) in dry toluene (3 mL). Deoxygenation was continued for 5 min. Azobisisobutyronitrile (AIBN) (0.02 g, 0.1 mmol) was added and the solution was heated at reflux for 9 h (TLC). The mixture was concentrated under reduced pressure and the residue was dissolved in EtOAc (5 mL). The solution was stirred with KF/H2O (15 mg/0.15 mL) for 3 h and extracted with EtOAc (3 × 20 mL). The combined organic phases were washed successively with water (20 mL) and brine (20 mL), and dried over anhydrous Na2SO4. After removal of the solvent, the crude product was purified by chromatography to give the desired products 4. Experimental procedures and compound characterization.
  13 in total

1.  Syntheses and biological activity of C-3'-difluoromethyl-taxoids.

Authors:  I Ojima; S Lin; J C Slater; T Wang; P Pera; R J Bernacki; C Ferlini; G Scambia
Journal:  Bioorg Med Chem       Date:  2000-07       Impact factor: 3.641

2.  A general strategy for construction of a difluoromethyl compound library and its application in synthesis of pseudopeptides bearing a terminal difluoromethyl group.

Authors:  Jingjing Wu; Song Cao; Nianjin Liu; Li Shen; Jinlong Yu; Jian Zhang; Hui Li; Xuhong Qian
Journal:  Org Biomol Chem       Date:  2010-03-17       Impact factor: 3.876

Review 3.  Recent developments in isocyanide based multicomponent reactions in applied chemistry.

Authors:  Alexander Dömling
Journal:  Chem Rev       Date:  2006-01       Impact factor: 60.622

4.  Novel fluorinated pseudopeptides as proteasome inhibitors.

Authors:  Lucia Formicola; Xavier Maréchal; Nicolas Basse; Michelle Bouvier-Durand; Danièle Bonnet-Delpon; Thierry Milcent; Michèle Reboud-Ravaux; Sandrine Ongeri
Journal:  Bioorg Med Chem Lett       Date:  2008-11-07       Impact factor: 2.823

5.  New fluorinated peptidomimetics through tandem aza-michael addition to alpha-trifluoromethyl acrylamide acceptors: synthesis and conformational study in solid state and solution.

Authors:  Santos Fustero; Gema Chiva; Julio Piera; Juan F Sanz-Cervera; Alessandro Volonterio; Matteo Zanda; Carmen Ramirez de Arellano
Journal:  J Org Chem       Date:  2009-04-17       Impact factor: 4.354

6.  Efficient synthesis of suitably protected beta-difluoroalanine and gamma-difluorothreonine from L-ascorbic acid.

Authors:  Gongyong Li; Wilfred A van der Donk
Journal:  Org Lett       Date:  2007-01-04       Impact factor: 6.005

Review 7.  Chiral dipeptide mimics possessing a fluoroolefin moiety: a relevant tool for conformational and medicinal studies.

Authors:  Samuel Couve-Bonnaire; Dominique Cahard; Xavier Pannecoucke
Journal:  Org Biomol Chem       Date:  2007-03-19       Impact factor: 3.876

8.  New antifungal 1,2,4-triazoles with difluoro(substituted sulfonyl)methyl moiety.

Authors:  H Eto; Y Kaneko; S Takeda; M Tokizawa; S Sato; K Yoshida; S Namiki; M Ogawa; K Maebashi; K Ishida; M Matsumoto; T Asaoka
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-02       Impact factor: 1.645

9.  Zinc chloride promoted formal oxidative coupling of aromatic aldehydes and isocyanides to alpha-ketoamides.

Authors:  Marinus Bouma; Géraldine Masson; Jieping Zhu
Journal:  J Org Chem       Date:  2010-04-16       Impact factor: 4.354

10.  Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.

Authors:  Francesca Olimpieri; Simone Tambaro; Santos Fustero; Paolo Lazzari; Maria Sanchez-Roselló; Luca Pani; Alessandro Volonterio; Matteo Zanda
Journal:  Bioorg Med Chem Lett       Date:  2009-06-21       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.